-
2
-
-
3543019740
-
Neuromuscular disorders: 1. Primary muscle disease and anterior horn cell disorders
-
Brett EM. editor. Edinburgh: Churchill Livingstone
-
Brett EM, Lake BD. (1991) Neuromuscular disorders: 1. Primary muscle disease and anterior horn cell disorders. In: Brett EM. editor. Paediatric Neurology. 2nd ed. Edinburgh: Churchill Livingstone. p 53-115.
-
(1991)
Paediatric Neurology. 2nd Ed.
, pp. 53-115
-
-
Brett, E.M.1
Lake, B.D.2
-
3
-
-
0026683048
-
Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease
-
Dubowitz LM, Bouza H, Hird MF, Jaeken J. (1992) Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease. Lancet 340: 80-1.
-
(1992)
Lancet
, vol.340
, pp. 80-81
-
-
Dubowitz, L.M.1
Bouza, H.2
Hird, M.F.3
Jaeken, J.4
-
5
-
-
0028175530
-
Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion
-
Kingsmore SF, Giros B, Suh D, Bieniarz M, Caron MG, Seldin MF. (1994) Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nature Genetics 7: 136-42.
-
(1994)
Nature Genetics
, vol.7
, pp. 136-142
-
-
Kingsmore, S.F.1
Giros, B.2
Suh, D.3
Bieniarz, M.4
Caron, M.G.5
Seldin, M.F.6
-
6
-
-
0026786240
-
Intrathecal baclofen in hereditary spastic paraparesis
-
Meythaler JM, Steers WD, Tuel SM, Cross LL, Sesco TD, Haworth CS. (1992) Intrathecal baclofen in hereditary spastic paraparesis. Archives of Physical Medicine and Rehabilitation 73: 794-7.
-
(1992)
Archives of Physical Medicine and Rehabilitation
, vol.73
, pp. 794-797
-
-
Meythaler, J.M.1
Steers, W.D.2
Tuel, S.M.3
Cross, L.L.4
Sesco, T.D.5
Haworth, C.S.6
-
7
-
-
0028580443
-
Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor
-
Rees MI, Andrew M, Jawad S, Owen MJ. (1994) Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. Human Molecular Genetics 3: 2175-9.
-
(1994)
Human Molecular Genetics
, vol.3
, pp. 2175-2179
-
-
Rees, M.I.1
Andrew, M.2
Jawad, S.3
Owen, M.J.4
-
8
-
-
0026651547
-
Startle disease or hyperexplexia: Response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis
-
Ryan SG, Sherman SL, Terry JC, Sparkes RS, Torres MC, Mackey RW. (1992) Startle disease or hyperexplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Annals of Neurology 31: 663-8.
-
(1992)
Annals of Neurology
, vol.31
, pp. 663-668
-
-
Ryan, S.G.1
Sherman, S.L.2
Terry, J.C.3
Sparkes, R.S.4
Torres, M.C.5
Mackey, R.W.6
-
9
-
-
0028333002
-
A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse
-
_ Buckwalter MS, Lynch JW, Handford CA, Segura L, Shiang R, Wasmuth JJ, Camper SA, Schofield P, O'Connell P. (1994) A missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nature Genetics 7: 131-5.
-
(1994)
Nature Genetics
, vol.7
, pp. 131-135
-
-
Buckwalter, M.S.1
Lynch, J.W.2
Handford, C.A.3
Segura, L.4
Shiang, R.5
Wasmuth, J.J.6
Camper, S.A.7
Schofield, P.8
O'Connell, P.9
-
10
-
-
0026006850
-
Nose tapping test inducing as generalised flexor spasm: A hallmark of hyperexplexia
-
Shahar E, Brand N, Uziel Y, Barak Y. (1991) Nose tapping test inducing as generalised flexor spasm: a hallmark of hyperexplexia. Acta Paediatrica Scandinavica 80: 1073-7.
-
(1991)
Acta Paediatrica Scandinavica
, vol.80
, pp. 1073-1077
-
-
Shahar, E.1
Brand, N.2
Uziel, Y.3
Barak, Y.4
-
11
-
-
0027330927
-
Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia
-
Shiang R, Ryan SG, Zhu Y-Z, Hahn AF, O'Connell P, Wasmuth JJ. (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genetics 5: 351-8.
-
(1993)
Nature Genetics
, vol.5
, pp. 351-358
-
-
Shiang, R.1
Ryan, S.G.2
Zhu, Y.-Z.3
Hahn, A.F.4
O'Connell, P.5
Wasmuth, J.J.6
-
12
-
-
0026638939
-
Vigabatrin for startle disease with altered cerebrospinal fluid free gamma aminobutyric acid
-
Stephenson JBP. (1992) Vigabatrin for startle disease with altered cerebrospinal fluid free gamma aminobutyric acid. Lancet 340: 430-1.
-
(1992)
Lancet
, vol.340
, pp. 430-431
-
-
Stephenson, J.B.P.1
|